- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Keratin 20 (KRT20) is a type I acidic cytokeratin that belongs to the epithelial intermediate filament protein family responsible for maintaining cytoskeletal structure and mechanical stability in epithelial cells. KRT20 Antibody for IF (clone CDI-11) enables visualization of Cytokeratin 20 filament networks by immunofluorescence microscopy, allowing researchers to study epithelial cell morphology, cytoskeletal organization, and cellular architecture. In immunofluorescence imaging, Keratin 20 staining typically appears as cytoplasmic filamentous labeling surrounding the nucleus, reflecting the intermediate filament bundles that form the structural scaffold of epithelial cells.
Keratin 20 is encoded by the KRT20 gene located on chromosome 17q21 within a genomic region containing several epithelial keratin genes. The protein is widely referred to in the literature as Cytokeratin 20 or CK20, two common synonyms frequently used in epithelial biology and tumor marker studies. Keratin 20 forms heterodimeric complexes with type II keratins such as keratin 8, and these dimers polymerize to generate extended intermediate filament networks throughout the cytoplasm. Immunofluorescence detection using a KRT20 Antibody for IF allows these filament networks to be visualized with high spatial resolution, revealing the organization of the epithelial cytoskeleton and the structural framework that maintains epithelial cell shape.
Keratin 20 expression is strongly associated with differentiated epithelial cell populations. High expression is observed in intestinal epithelial cells, gastric mucosa, and urothelial umbrella cells, where KRT20 contributes to epithelial barrier integrity and structural stability. Because of this tissue-restricted distribution, Cytokeratin 20 antibody staining is widely used to identify epithelial lineage cells in biological samples. Immunofluorescence imaging with a KRT20 Antibody for IF can highlight cytoplasmic filament networks within epithelial cells and provide clear visualization of epithelial cell boundaries and morphology when examined by fluorescence microscopy.
In cancer research, Keratin 20 expression is frequently retained in tumors derived from gastrointestinal and urothelial epithelia. CK20 expression is commonly observed in colorectal carcinoma, gastric carcinoma, pancreatic carcinoma, and bladder carcinoma, where it serves as a marker of epithelial differentiation. Immunofluorescence staining with a KRT20 Antibody for IF allows investigators to examine cytoskeletal architecture and epithelial identity within tumor cell populations. Fluorescence microscopy can reveal the filamentous cytoplasmic distribution of Keratin 20 in cancer cells and may assist studies of epithelial differentiation, tumor organization, and cytoskeletal remodeling during tumor progression.
The recombinant rabbit monoclonal antibody clone CDI-11 targets Keratin 20 and can be used to detect KRT20 protein distribution in fixed cells and tissue samples for research applications. In immunofluorescence experiments, Keratin 20 labeling typically produces a filamentous cytoplasmic fluorescence pattern that outlines epithelial intermediate filament networks. This staining pattern enables visualization of epithelial cytoskeletal organization, supports studies of epithelial differentiation and morphology, and facilitates high resolution imaging of epithelial cell structure in fluorescence microscopy experiments.
Optimal dilution of the KRT20 Antibody for IF should be determined by the researcher.
A synthesized peptide derived from human Cytokeratin 20 was used as the immunogen for the KRT20 antibody for IF.
Store the KRT20 antibody at -20oC.
Cytokeratin 20 antibody, CK20 antibody, Keratin 20 antibody, Cytokeratin-20 antibody, KRT20 protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.